Compared with nonpharmacologic approaches, research consistently supports the benefits of medication for opioid use disorder, including fewer deaths, higher rates of sustained recovery, and greater cost-effectiveness.
The American Academy of Pediatrics (AAP) released a policy statement and an accompanying clinical report on identifying and addressing the effects of trauma and stress on children, families, and their health care providers.
A review by Ebrahimi and colleagues, and an interview with Beth Cohen, MD, highlights the possible mechanisms driving the association between posttraumatic stress disorder and cardiovascular disease, and the need for screening and treatment options for these patients.
Recent studies have shown an increase in depression and suicidality in transgender youth. To learn more about the mental health challenges affecting transgender youth and how clinicians can better support these patients, we interviewed Jason V. Lambrese, MD, staff child and adolescent psychiatrist at Cleveland Clinic’s Lakewood Family Health Canter in Lakewood, Ohio, and Ralph Vetters, MD, MPH, pediatrician and site medical director at the Sidney Borum Jr. Health Center, a program of Fenway Health in Boston.
Patients with depression can live with symptoms for a long period of time before finding an option that works. One possibility for patients who are unable to find relief through pharmacology is transcranial magnetic stimulation. An expert offers his view on this form of treatment.
With significant racial inequities existing in access to services for youth with autism spectrum disorder, we spoke with an expert about how those in health care can work together to close these gaps and destigmatize disparities.
Prior to the COVID-19 pandemic, that more than 60% of US adults were lonely; these numbers only increased during the pandemic. Clinicians should focus more time on the psychological and social factors of aging to improve the quality of life of the elderly.
There has been an ongoing evolution in the treatment of psychosis, schizophrenia, bipolar, and other significant psychiatric morbidities. As therapies have evolved, efficacy in treating positive and negative symptoms has (for the most part) remained quite high, and there has been a concerted push to — as the generations of drugs progress ever-forward — reduce the off-target and unwanted side effects of treatment (which also helps to boost compliance with medication-taking behaviors). Dr Ben Locwin shares his expertise on the future of pharmacologic treatment.
With health experts across the country agreeing we are in the midst of a mental health pandemic, psychiatrist Aaron M. Hawkins, MD offers his view about the current state and the future of mental health in the United States.
A survey of health care providers found a lack of knowledge on idiopathic hypersomnia (IH) among physicians, and that the disorder is often misdiagnosed. We spoke with Richard Bogan, MD, FCCP, FAASM, associate clinical professor at the University of the South Carolina School of Medicine about IH and criteria for diagnosing this sleep disorder.
Data from the CDC on suicide deaths indicate a 5.6% decline in suicide deaths between 2019 and 2020 in the United States. We spoke with Christine Yu Moutier, MD, Chief Medical Officer for the American Foundation for Suicide Prevention (AFSP) about this data.
Hanna Saltzman, MD, speaks to the importance of screening for and addressing mental health in a pediatric rheumatology population and discusses the efforts initiated by CARRA workgroups in this direction. A patient with childhood SLE also provides her perspective.
The unprecedented numbers of patients on mechanical ventilation underscore the severity of the coronavirus on public health. Elderly patients, especially those with Parkinson disease, often bear the brunt of the pandemic due to pre-existing pulmonary disease and/or anatomical disposition.
After decades of limited research and legal roadblocks to medical and recreational use, psychedelic drugs are rapidly remerging as treatments of interest in psychiatry. We interviewed two experts in the field.
Even before the COVID-19 pandemic began, concerning mental health trends and major treatment gaps were noted among adolescents. We spoke with Cécile Rousseau, MD, researcher, psychiatrist, and professor in the division of social and transcultural psychiatry at McGill University in Montreal, Canada about the impact of the COVID-19 pandemic on adolescent mental health.
The COVID-19 pandemic led to an exacerbation of pre-existing hardships and disparities in many vulnerable populations, including individuals affected by intimate partner violence. We interviewed experts in the field to learn more about this issue and how clinicians may best assist affected individuals.
With teens relying heavily on their friends and social connections for emotional support, the restrictions imposed to contain COVID-19 are especially hard on them. The C.S. Mott Children’s Hospital National Poll on Children’s Health asked a national sample of parents about the emotional impact pandemic restrictions have had on their teens aged 13 to 18.
For the 12-month period ending in May 2020, the CDC reported 81,000 drug overdose deaths — the most ever recorded in a 12-month period in the United States. We interviewed Danielle F. Haley, MPH, PhD, assistant professor in the department of community health sciences at the Boston University School of Public Health about COVID-19 and the rates of substance abuse and overdose cases.